@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix au: <http://www.w3.org/2015/03/inspire/au#> .
@prefix bc: <https://ontology.bommaritollc.com/vocab/core/> .
@prefix bcgeo: <https://ontology.bommaritollc.com/vocab/geo/> .
@prefix bcleg: <https://ontology.bommaritollc.com/vocab/leg/> .
@prefix bcorg: <https://ontology.bommaritollc.com/vocab/org/> .
@prefix bcsec: <https://ontology.bommaritollc.com/vocab/sec/> .
@prefix bcweb: <https://ontology.bommaritollc.com/vocab/web/> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix eli: <http://data.europa.eu/eli/ontology#> .
@prefix geo: <http://www.opengis.net/ont/geosparql#> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opengov: <http://www.w3.org/ns/opengov#> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix pav: <http://purl.org/pav/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix semapv: <https://w3id.org/semapv/vocab/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix skosxl: <http://www.w3.org/2008/05/skos-xl#> .
@prefix sssom: <https://w3id.org/sssom/> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5> eli:cites <https://ontology.bommaritollc.com/id/01a0ee02-5baf-7709-a77d-8b2fd0d8778e>, <https://ontology.bommaritollc.com/id/01a0ee02-5bb1-70d8-b926-bbbd0fba6d2d>, <https://ontology.bommaritollc.com/id/01a0ee02-5bb4-702a-8500-82be1cde83ae>, <https://ontology.bommaritollc.com/id/01a0ee02-5bb5-72f4-af4e-236060676852> ;
    a schema:Legislation ;
    skos:prefLabel "49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?"@en ;
    adms:identifier <https://ontology.bommaritollc.com/id/01a0ee02-5bd4-752d-b70d-0721932bd884> ;
    prov:wasDerivedFrom <https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0>, <https://ontology.bommaritollc.com/id/01a0ee02-a4d6-748b-bd3b-8d128b7da622>, <https://ontology.bommaritollc.com/id/01a0ee05-8cd5-74e3-b6bd-9ad2ccdd5ef4>, <https://ontology.bommaritollc.com/id/01a10f18-2b0d-7629-b45a-d7faf7abd645> ;
    schema:isPartOf <https://ontology.bommaritollc.com/id/01a0ee02-0928-7725-aab6-beebeb4a8fc8> ;
    schema:legislationIdentifier "49 CFR 40.177" ;
    schema:legislationJurisdiction <https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0> ;
    schema:legislationLegalForce schema:InForce ;
    schema:legislationType bcleg:cfrSection ;
    schema:name "What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?"@en ;
    schema:url <https://www.govinfo.gov/link/cfr/49/40?sectionnum=177&year=mostrecent&link-type=details> .
